UK markets open in 2 hours 45 minutes

Sinopharm Group Co. Ltd. (X2S.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.1850-0.0070 (-0.32%)
At close: 05:06PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 6.94B
Enterprise value 10.52B
Trailing P/E 6.10
Forward P/E 6.62
PEG ratio (5-yr expected) 50.46
Price/sales (ttm)0.09
Price/book (mrq)0.77
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.43

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3-3.78%
S&P500 52-week change 3-6.69%
52-week high 32.4500
52-week low 31.8285
50-day moving average 32.2581
200-day moving average 32.0980

Share statistics

Avg vol (3-month) 32.08k
Avg vol (10-day) 3907
Shares outstanding 51.34B
Implied shares outstanding 6N/A
Float 81.34B
% held by insiders 10.01%
% held by institutions 154.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.11
Forward annual dividend yield 44.82%
Trailing annual dividend rate 30.75
Trailing annual dividend yield 334.22%
5-year average dividend yield 42.95
Payout ratio 428.07%
Dividend date 3N/A
Ex-dividend date 427 Jun 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 1.51%
Operating margin (ttm)4.07%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)13.87%

Income statement

Revenue (ttm)528.38B
Revenue per share (ttm)169.51
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)44.05B
EBITDA 23.47B
Net income avi to common (ttm)7.97B
Diluted EPS (ttm)0.3600
Quarterly earnings growth (yoy)17.40%

Balance sheet

Total cash (mrq)35.91B
Total cash per share (mrq)11.51
Total debt (mrq)81.27B
Total debt/equity (mrq)79.46
Current ratio (mrq)1.30
Book value per share (mrq)20.34

Cash flow statement

Operating cash flow (ttm)7.66B
Levered free cash flow (ttm)N/A